Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNORE study of mometasone furoate nasal spray in children with adenoid hypertrophy
2014-004917-10Phase 3
- Sponsor
- Merck & Co.
- Start
- Mar 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in adenoidal hypertrophy comparing Nasonex with Placebo (2 arms). Primary endpoint: Reduction in adenoid size.
02
Drugs
mometasone
03
Conditions
adenoidal hypertrophy
Beyond the preview
Go deeper on 2014-004917-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004917-10.